Regarding Merck, Too small of a data set Thinks it wasn't large enough to show full safety and efficacy FDA wants to see larger trials, only 200ish patients HGEN now up to 700 patients Glad they expanded it
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.